Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 162,007 | 97,185 | 85,721 | 64,897 | 81,659 |
| Marketable Securities | 983,339 | 644,282 | 670,812 | 421,301 | 444,921 |
| TOTAL | $1,173,003 | $763,953 | $777,781 | $504,604 | $538,832 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $1,173,003 | $763,953 | $777,781 | $504,604 | $538,832 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,768 | 5,742 | 8,918 | 11,427 | 3,743 |
| Accrued Expenses | 26,184 | 29,160 | 26,947 | 23,827 | 19,416 |
| Other current liabilities | 31,350 | 50,260 | 22,820 | 11,020 | 59,900 |
| TOTAL | $63,302 | $85,162 | $58,685 | $46,274 | $83,059 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 8,560 | 7,980 | 3,860 | 3,230 | 0 |
| TOTAL | $8,560 | $7,980 | $3,860 | $3,230 | $N/A |
| Total Liabilities | $71,862 | $93,142 | $62,545 | $49,504 | $83,059 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 88,174 | 86,841 | 78,540 | 77,592 | 60,401 |
| Common Shares | 16 | 15 | 15 | 13 | 13 |
| Retained earnings | -1,232,840 | -1,196,640 | -1,127,635 | -1,065,105 | -1,053,922 |
| Other shareholders' equity | 144,029 | 155,053 | 156,689 | 156,611 | 156,274 |
| TOTAL | $1,101,141 | $670,811 | $715,236 | $455,100 | $455,773 |
| Total Liabilities And Equity | $1,173,003 | $763,953 | $777,781 | $504,604 | $538,832 |